Edited by Linda SpremulliCytoskeletal filamin A (FLNA) is an important protein involved in multiple cellular processes. Previous studies have shown that FLNA can promote or inhibit cancer growth and development; however, the mechanisms underlying these events are not fully understood. Here we show that, in both 293T and SaOS2 cells, knockdown of FLNA significantly enhanced transcription of RNA polymerase (pol) III-transcribed genes except for a subset of tRNA genes. In contrast, re-expression of FLNA in an FLNA-deficient melanoma cell line (A7) repressed transcription of all pol III-transcribed genes, suggesting that FLNA inhibits pol III transcription in a cell type-specific manner. Chromatin immunoprecipitation assays revealed that the repression of pol III gene transcription by FLNA correlates with the decreased occupancy of the RNA pol III transcription machinery at promoters. Immunofluorescence microscopy and coimmunoprecipitation assays revealed that FLNA can associate with the RNA pol III transcription machinery through its actin-binding domain within nuclei. Mechanistic analysis revealed that FLNA suppresses pol III gene transcription by confining the recruitment of the RNA pol III transcription machinery at the promoters of the genes that are sensitive to the alteration of FLNA expression. These findings not only extend the understanding of FLNA function in cells but also provide novel insights into the mechanism by which FLNA represses cell proliferation.Eukaryotic RNA polymerase (pol) 3 III mediates the synthesis of many non-coding RNAs that include tRNA, 5S rRNA, U6 RNA, 7SL RNA, and other small RNAs. These RNA products account for about 15% of total cellular transcripts and are involved in the regulation of protein biogenesis, RNA splicing, protein transportation, and protein-coding gene transcription (1-3). In cancer, aberrant expression of pol III products strongly correlates with the transformed state (4 -6). Abnormal high expression of pol III products in cancer is attributed to increased expression of pol III transcription factors, discharge of repression by tumor suppressors, and activation of oncogene expression (2).Cytoskeletal filamin A (FLNA) is a 280-kDa protein comprised of two N-terminal calponin homology domains and a long C-terminal rod-like domain. FLNA cross-links with F-actin through the calponin homology domains to maintain the stability of the cellular 3D network. In addition, FLNA acts as a scaffold that binds to over 90 diverse functional proteins to regulate numerous cellular processes (7-9), including cell adhesion, migration, proliferation, angiogenesis, cell signaling, DNA repair, and transcription (10 -18). It is well established that FLNA mutations cause several congenital diseases, including defects of the brain, heart, and skeleton (8). FLNA can play dual roles in cancer development; that is, FLNA can promote or inhibit cancer growth and development depending on particular circumstances (10). However, the mechanisms underlying these events are not fully understood.We sh...